Treatment optimization guidelines for hyperthermic antiblastic limb perfusion

In our experience, consisting of 175 hyperthermic antiblastic regional perfusions in extracorporeal circulation (ECC) for limb malignancies, a primary objective has been the improvement of the technical aspects that constitute the basis of the method [1–3, 7]. Our interest has been therefore devoted to verifying and optimizing the following main points.